Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Perry · SciRah

Researcher profile · Semantic Scholar

D. Perry

Share profile

D. Perry — researcher profile on SciRah

h-index: 12
Works: 59
Citations: 493

Most-cited papers

Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy.
T. Allweis, M. Boisvert, S. Otero, D. Perry +2 more
2002American Journal of Surgery104 citations
Semantic Scholar
Survival After Induction Chemotherapy and Surgical Resection for High-Grade Soft Tissue Sarcoma. Is Radiation Necessary?
R. Henshaw, D. Priebat, D. Perry, B. Shmookler +1 more
2001Annals of Surgical Oncology47 citations Open access
Semantic Scholar
Eosinophilia associated with adult t‐cell leukemia/lymphoma
S. Vukelja, R. Weiss, D. Perry, D. Longo
1988Cancer40 citations Open access
Semantic Scholar
High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancer.
D. Perry, Kelvin K. W. Chan, S. Wolden, M. Zelefsky +6 more
2010International Journal of Radiation Oncology, Biology, Physics38 citations
Semantic Scholar
Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Renal Cell Cancer (RCC) after Sunitinib Failure
N. Tannir, Y. Wong, C. Kollmannsberger, M. Ernstoff +14 more
2011European Journal of Cancer34 citations Open access
Semantic Scholar
Enhanced bleomycin toxicity during acute renal failure.
D. Perry, R. Weiss, H. Taylor
1982Cancer treatment reports30 citations
Semantic Scholar
Delayed reversible posterior encephalopathy syndrome following chemotherapy with oxaliplatin.
U. Sharief, D. Perry
2009Clinical colorectal cancer28 citations
Semantic Scholar
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
L. Diehl, D. Perry, H. Terebelo, P. Baldwin +3 more
1983Cancer treatment reports24 citations
Semantic Scholar
Chemotherapy with 5‐fluorouracil (5‐FU) and cisplatin or 5‐FU, cisplatin, and vinblastine for advanced non‐small cell lung cancer. A randomized phase II study of the cancer and leukemia group B
F. Ii, D. Perry, Maria Goutsou, Caron Modeas +6 more
1991Cancer20 citations Open access
Semantic Scholar
Vinblastine, bleomycin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck
D. Perry, Martin D. Weltz, Archie W. Brown, Robert L. Henderson +2 more
1982Cancer16 citations Open access
Semantic Scholar
Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitis
M. Tallman, R. McGuffin, C. Higano, G. Starkebaum +5 more
1987American journal of hematology/oncology14 citations
Semantic Scholar
Carboplatin for advanced colorectal carcinoma: a phase II study.
D. Perry, R. Weiss, S. Creekmore, K. Micetich +1 more
1986Cancer treatment reports13 citations
Semantic Scholar
Phase II trial of ABT-869 in advanced renal cell cancer (RCC) after sunitinib failure: Efficacy and safety results.
N. Tannir, Y. Wong, C. Kollmannsberger, M. Ernstoff +6 more
2009Journal of Clinical Oncology11 citations
Semantic Scholar
Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma.
M. Weltz, D. Perry, J. Blom, W. Butler
1983Journal of Clinical Oncology11 citations
Semantic Scholar
Cisplatin and mitoguazone: An induction chemotherapy regimen in advanced head and neck cancer
A. Forastiere, D. Perry, G. Wolf, Richard H. Wheeler +1 more
1988Cancer9 citations
Semantic Scholar
Phase II trial of linifanib in patients with advanced renal cell cancer (RCC) after sunitinib failure.
N. Tannir, Y. Wong, C. Kollmannsberger, M. Ernstoff +6 more
20107 citations
Semantic Scholar
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
D. Perry, S. Crain, M. Weltz, J. Wilson +5 more
1983Cancer treatment reports7 citations
Semantic Scholar
Rare case of hepatocellular carcinoma metastasising to the pituitary and cavernous sinus causing panhypopituitarism and bilateral ophthalmoplegia
J. Ambalavanan, M. Peravali, D. Perry
2020BMJ Case Reports4 citations Open access
Semantic Scholar
PDQ—A database of clinical trials and cancer treatment information
D. Perry, S. Hubbard
1988Cancer Metastasis Review4 citations
Semantic Scholar
Multimodality therapy for unresectable squamous cell carcinoma of the head and neck
D. Perry, R. Davis, J. Duttenhaver, J. Zajtchuk +3 more
1985American Journal of Clinical Oncology4 citations
Semantic Scholar
Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
A. Forastiere, S. Crain, C. Garbino, S. Tipping +3 more
1984Cancer treatment reports4 citations
Semantic Scholar
Intensive CT scan surveillance for patients who have undergone curative intent treatment for colorectal cancer: The Medstar Washington Hospital Center experience.
Konstantinos Leventakos, S. Lu, D. Perry
20133 citations
Semantic Scholar
Phase II trial of concurrent paclitaxel, carboplatin, and external-beam radiation followed by surgical resection in locally advanced non-small-cell lung cancer, protocol 99-444.
Sean A. Fischer, Mark S. Soberman, P. Randolph, K. Crawford +1 more
2006Clinical Lung Cancer3 citations
Semantic Scholar
Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
Michele Z Magnino, D. Perry, Deepa S. Subramaniam, C. DeKlotz
2020Journal of American Academy of Dermatology2 citations
Semantic Scholar
Abstract 5656: Quantitative measurement of PDL1 expression across tumor types using laser capture microdissection and reverse phase protein microarray
E. Baldelli, V. Calvert, K. A. Hodge, M. Sereni +12 more
20172 citations
Semantic Scholar
7109 Phase 2 results of ABT-869 treatment in patients with advanced renal cell cancer (RCC) after sunitinib failure
N. Tannir, Y. Wong, C. Kollmannsberger, M. Ernstoff +6 more
20092 citations
Semantic Scholar
The PDQ database: what the primary care physician needs to know about current treatments for cancer and AIDS.
D. Tingley, S. Hubbard, D. Perry
1988The Journal of medical practice management : MPM2 citations
Semantic Scholar
Clinical predictors of response in metastatic germ cell tumors
Grant Taylor, D. Perry, Robert D. Knight, N. Dawson +2 more
1988Cancer2 citations Open access
Semantic Scholar
Phase II study of deoxydoxorubicin in patients with advanced liver cancer.
D. Perry, D. V. van Echo, R. Mick
1987Cancer treatment reports2 citations
Semantic Scholar
2197: Comparison of Second Cancer Risk in Prostate Cancer Patients Treated With Neutron/Photon Irradiation, Photon Irradiation, or Prostatectomy
L. McGee, C. Bock, D. Perry, S. Bolton +2 more
20061 citations
Semantic Scholar
Reversible microangiopathic hemolytic anemia after mitomycin C
D. Perry
2004Cancer Chemotherapy and Pharmacology1 citations
Semantic Scholar
Cost analysis of high vs. low activity iodine-125 seeds as monotherapy for permanent prostate brachytherapy
D. Perry, R. Patel, M. Yudelev, S. Keole +3 more
20041 citations
Semantic Scholar
Dose Modification for PDQ.
D. Perry, S. Hubbard, D. Masys, D. Tingley
19871 citations
Semantic Scholar
Hypersensitivity reactions to amsacrine.
D. Perry, R. Weiss, D. Hoth
1985Cancer treatment reports1 citations
Semantic Scholar
Induction Chemotherapy with Vinblastine, Bleomycin, and cis-Diamminedichloroplatinum in Squamous Cell Carcinoma of the Head and Neck
R. Davis, D. Perry, J. Zajtchuk
1983Otolaryngology Head & Neck Surgery1 citations
Semantic Scholar
Anal cancer: Outcomes in men who have sex with men.
M. Chaudhry, A. Cruz, D. Perry
20160 citations
Semantic Scholar
Comparing the efficacies of neoadjuvant non-cisplatin-based and cisplatin-based chemotherapies in obtaining pathologic complete remissions in muscle-invasive bladder cancer.
P. Sivakumaran, V. Ranpura, D. Perry
20130 citations
Semantic Scholar
Abstract C24: Phase I trial of dasatinib and ixabepilone in patients with solid tumors.
P. Herbolsheimer, Rita Kapoor, K. Smith, D. Perry +4 more
20110 citations
Semantic Scholar
A phase I study of ixabepilone combined with dasatinib in patients with solid tumors.
C. Kaiser, D. Perry, A. Zimmer, J. Patterson +1 more
20100 citations
Semantic Scholar
Prospective evaluation of prognostic factors for recurrence after complete surgical resection of gastrointestinal stromal tumors (GIST)
V. Suhag, D. Perry, D. Kumar, L. Amiri-Kordestani +2 more
20080 citations
Semantic Scholar
Intravaginal brachytherapy (IVRT) alone for patients with endometrial cancer meeting the PORTEC inclusion criteria
D. Perry, N. Abu-Rustum, D. Chi, R. Barakat +1 more
20070 citations
Semantic Scholar
High Dose Rate Intraoperative Radiotherapy for Recurrent Head and Neck Cancer
Kelvin K. W. Chan, D. Perry, S. Wolden, M. Zelefsky +6 more
20070 citations
Semantic Scholar
High Dose Rate Intraoperative Radiation Therapy for Locally Recurrent Neuroblastoma
D. Perry, M. LaQuaglia, Kelvin K. W. Chan, K. Goodman +1 more
20070 citations Open access
Semantic Scholar
2315 : Salvage Permanent Prostate Brachytherapy in Patients With Local Recurrence Following External Beam Irradiation
M. Yudelev, D. Perry, J. Forman, M. Cher
20060 citations
Semantic Scholar
2317 : Outcomes of Dose-Escalation Using an Image-Guided, Hypofractionated, Intensity-Modulated Radiotherapy Boost for Localized Prostate Cancer
R. Shridhar, D. Perry, S. Bolton, M. Joiner +1 more
20060 citations Open access
Semantic Scholar
2261 : Long-Term Outcome of Four Dose Schedules of Mixed 3-D Conformal Neutron and Photon Irradiation in the Treatment of Prostate Cancer
J. Forman, D. Perry, L. Essenmacher, L. McGee +3 more
20060 citations
Semantic Scholar
2270 : Combined Fast Neutron Irradiation and Permanent Prostate Brachytherapy in Intermediate and Poor Risk Prostate Cancer: Expanded Results of Phase II Trial
Rajiv J. Patel, J. Forman, M. Cher, D. Perry +3 more
20060 citations Open access
Semantic Scholar
2221 : The Outcome of Intermediate Risk Prostate Cancer Treated With Escalated Dose Radiation With or Without Neoadjuvant Hormone Therapy
D. Perry, L. McGee, L. Essenmacher, S. Bolton +2 more
20060 citations
Semantic Scholar
Combination of Fast Neutron Irradiation and Permanent Prostate Brachytherapy in Intermediate and High Risk Localized Prostate Cancer
D. Perry, R. Patel, C. Zúñiga, M. Cher +4 more
20050 citations Open access
Semantic Scholar
Outcome and Toxicity of Patients with PSA Levels ≥ 20 Treated with Fast Neutron Irradiation
R. Patel, D. Perry, J. Maier, Zong-Shan Lai +3 more
20050 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Forman×8
Invite
J. Forman — researcher profile on SciRah
S. Bolton×6
Invite
S. Bolton — researcher profile on SciRah
R. Weiss×4
Invite
R. Weiss — researcher profile on SciRah
N. Tannir×4
Invite
N. Tannir — researcher profile on SciRah

×4

Invite

Y. Wong — researcher profile on SciRah

Invite

M. Ernstoff — researcher profile on SciRah

Invite

L. Appleman — researcher profile on SciRah

Invite

E. Posadas — researcher profile on SciRah

Invite

J. Qian — researcher profile on SciRah

Invite

J. Ricker — researcher profile on SciRah

Invite

J. Ager — researcher profile on SciRah

Invite

D. Priebat — researcher profile on SciRah